164 related articles for article (PubMed ID: 18807155)
1. Long-term neurocognitive function of pediatric patients with severe combined immune deficiency (SCID): pre- and post-hematopoietic stem cell transplant (HSCT).
Lin M; Epport K; Azen C; Parkman R; Kohn DB; Shah AJ
J Clin Immunol; 2009 Mar; 29(2):231-7. PubMed ID: 18807155
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.
Bjoraker KJ; Delaney K; Peters C; Krivit W; Shapiro EG
J Dev Behav Pediatr; 2006 Aug; 27(4):290-6. PubMed ID: 16906003
[TBL] [Abstract][Full Text] [Related]
3. Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies.
Shah AJ; Epport K; Azen C; Killen R; Wilson K; De Clerck D; Crooks G; Kapoor N; Kohn DB; Parkman R; Weinberg KI
J Pediatr Hematol Oncol; 2008 Jun; 30(6):411-8. PubMed ID: 18525456
[TBL] [Abstract][Full Text] [Related]
4. Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection.
Abdel-Azim H; Mahadeo KM; Zhao Q; Khazal S; Kohn DB; Crooks GM; Shah AJ; Kapoor N
Am J Hematol; 2015 Nov; 90(11):1021-6. PubMed ID: 26242764
[TBL] [Abstract][Full Text] [Related]
5. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab.
Das-Gupta EP; Russell NH; Shaw BE; Pearce RM; Byrne JL
Biol Blood Marrow Transplant; 2007 Jun; 13(6):724-33. PubMed ID: 17531783
[TBL] [Abstract][Full Text] [Related]
7. Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor.
Taverna L; Tremolada M; Bonichini S; Tosetto B; Basso G; Messina C; Pillon M
PLoS One; 2017; 12(10):e0186787. PubMed ID: 29065156
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
[TBL] [Abstract][Full Text] [Related]
9. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
[TBL] [Abstract][Full Text] [Related]
10. Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.
Lee JW; Kang HJ; Kim S; Lee SH; Yu KS; Kim NH; Jang MK; Kim H; Song SH; Park JD; Park KD; Shin HY; Jang IJ; Ahn HS
Biol Blood Marrow Transplant; 2015 Jan; 21(1):190-5. PubMed ID: 25255163
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study.
Kupst MJ; Penati B; Debban B; Camitta B; Pietryga D; Margolis D; Murray K; Casper J
Bone Marrow Transplant; 2002 Nov; 30(9):609-17. PubMed ID: 12407436
[TBL] [Abstract][Full Text] [Related]
12. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.
Gennery AR; Dickinson AM; Brigham K; Barge D; Spickett GP; Curtis A; Spencer V; Jackson A; Cavanagh G; Carter V; Palmer P; Flood TJ; Cant AJ; Abinun M
Cytotherapy; 2001; 3(3):221-32. PubMed ID: 12171729
[TBL] [Abstract][Full Text] [Related]
13. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.
Dorsey MJ; Wright NAM; Chaimowitz NS; Dávila Saldaña BJ; Miller H; Keller MD; Thakar MS; Shah AJ; Abu-Arja R; Andolina J; Aquino V; Barnum JL; Bednarski JJ; Bhatia M; Bonilla FA; Butte MJ; Bunin NJ; Chandra S; Chaudhury S; Chen K; Chong H; Cuvelier GDE; Dalal J; DeFelice ML; DeSantes KB; Forbes LR; Gillio A; Goldman F; Joshi AY; Kapoor N; Knutsen AP; Kobrynski L; Lieberman JA; Leiding JW; Oshrine B; Patel KP; Prockop S; Quigg TC; Quinones R; Schultz KR; Seroogy C; Shyr D; Siegel S; Smith AR; Torgerson TR; Vander Lugt MT; Yu LC; Cowan MJ; Buckley RH; Dvorak CC; Griffith LM; Haddad E; Kohn DB; Logan B; Notarangelo LD; Pai SY; Puck J; Pulsipher MA; Heimall J
J Clin Immunol; 2021 Jan; 41(1):38-50. PubMed ID: 33006109
[TBL] [Abstract][Full Text] [Related]
14. Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT).
Guffon N; Pettazzoni M; Pangaud N; Garin C; Lina-Granade G; Plault C; Mottolese C; Froissart R; Fouilhoux A
Orphanet J Rare Dis; 2021 Jan; 16(1):60. PubMed ID: 33517895
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive function of patients with severe combined immunodeficiency.
Shah AJ; Kohn DB
Immunol Allergy Clin North Am; 2010 Feb; 30(1):143-51. PubMed ID: 20113891
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of busulfan, cladribine and alemtuzumab as reduced intensity conditioning for stem cell transplantation.
Halaburda K; Marianska B; Warzocha K; Nasilowska-Adamska B; Szczepinski A; Tomaszewska A; Sawecka J; Skulimowska J
Ann Transplant; 2009; 14(2):7-12. PubMed ID: 19487787
[TBL] [Abstract][Full Text] [Related]
17. Developmental outcomes and cognitive functioning in infant and child heart transplant recipients.
Baum M; Freier MC; Freeman KR; Chinnock RE
Prog Pediatr Cardiol; 2000 Jun; 11(2):159-163. PubMed ID: 10856697
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
Ahmed N; Leung KS; Rosenblatt H; Bollard CM; Gottschalk S; Myers GD; Carrum G; Heslop HE; Brenner MK; Krance RA
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1298-304. PubMed ID: 18940685
[TBL] [Abstract][Full Text] [Related]
19. Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience.
Hamidieh AA; Alimoghaddam K; Jahani M; Bahar B; Mousavi SA; Iravani M; Behfar M; Jalali A; Jalili M; Hamdi A; Ghavamzadeh A
J Pediatr Hematol Oncol; 2013 Aug; 35(6):e239-45. PubMed ID: 23042019
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
